Lynx Equity Strategies analysts suggest Trump’s criticism may be aimed at pressuring Intel to restart manufacturing expansion ...

Investing.com -- C3.ai shares plunged more than 31% premarket Monday after the software maker posted preliminary fiscal first ...

Investing.com -- Viatris Inc (NASDAQ: VTRS) stock rose 2.6% following the U.S. Food and Drug Administration’s approval of the company’s Iron Sucrose Injection, USP, the first generic version of ...

Investing.com -- Bernstein raised its rating on Sabre (NASDAQ: SABR) to Outperform from Market-perform, saying the market is too pessimistic on the travel technology company’s outlook and is pricing ...

Investing.com -- Barrick Mining CEO Mark Bristow said Monday that potential U.S. tariffs on gold bars would have minimal impact on mining companies as they are "price takers." Speaking to Reuters, ...

VivoPower will become the first publicly listed company in the United States providing shareholders with exposure to both Ripple shares and XRP tokens. The company will have full legal title to the ...

Following the suspension, VSee’s common stock and warrants will transition to trading on the OTC Markets system under the same symbols "VSEE" and "VSEEW," respectively. The company plans to appeal the ...

Investing.com -- IO Biotech (NASDAQ: IOBT) stock rose 6.1% after announcing topline results from its pivotal Phase 3 trial of Cylembio, an investigational cancer vaccine, in combination with Merck ...

Investing.com -- Morgan Stanley raised its rating on elf Beauty to Overweight from Equal-weight, saying investor concerns about slowing U.S. sales, price increases and the recent Rhode acquisition ...

Investing.com -- Amphastar Pharmaceuticals (NASDAQ: AMPH) stock gained 4% after the company announced FDA approval for its generic version of iron sucrose injection, a treatment for iron deficiency ...